BioNTech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:51 PM EDT
222.00quote price arrow up+1.42 (+0.64%)
Volume
9,083
Close
220.58quote price arrow down-17.97 (-7.53%)
Volume
4,356,892
52 week range
48.29 - 252.78

...

Loading . . .
  • Open240.55
  • Day High240.92
  • Day Low212.40
  • Prev Close238.55
  • 52 Week High252.78
  • 52 Week High Date06/07/21
  • 52 Week Low48.29
  • 52 Week Low Date06/15/20

Key Stats

  • Market Cap53.274B
  • Shares Out241.52M
  • 10 Day Average Volume2.76M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change170.58

KEY STATS

  • Open240.55
  • Day High240.92
  • Day Low212.40
  • Prev Close238.55
  • 52 Week High252.78
  • 52 Week High Date06/07/21
  • 52 Week Low48.29
  • 52 Week Low Date06/15/20
  • Market Cap53.274B
  • Shares Out241.52M
  • 10 Day Average Volume2.76M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change170.58

RATIOS/PROFITABILITY

  • EPS (TTM)5.33
  • P/E (TTM)41.36
  • Fwd P/E (NTM)6.06
  • EBITDA (MRQ)2.036B
  • ROE (MRQ)80.65%
  • Revenue (MRQ)3.03B
  • Gross Margin (MRQ)88.55%
  • Net Margin (MRQ)47.81%
  • Debt To Equity (MRQ)23.21%

EVENTS

  • Earnings Date08/12/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
452.14-1.03-0.23%
SGEN
Seagen Inc
156.29-0.29-0.19%
MRNA
Moderna Inc
207.41-11.44-5.23%
GMAB
Genmab A/S
44.14+0.40+0.91%
INCY
Incyte Corp
82.64+0.06+0.07%